Frontiers in Psychiatry | Psychopharmacology

Original Research

Published on 02 Aug 2024

Characteristics of eye disorders induced by atypical antipsychotics: a real-world study from 2016 to 2022 based on Food and Drug Administration Adverse Event Reporting System

in Psychopharmacology

Chao Mu
Li Chen

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1322939

7,714 views
5 citations

Case Report

Published on 01 Aug 2024

Sertraline induced acute hepatocellular liver injury in patient with major depressive disorder: a case report

in Psychopharmacology

Lubova Renemane
Elmars Rancans

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1456455

13,723 views
3 citations

Case Report

Published on 31 Jul 2024

Case report: two cases of rhabdomyolysis following esketamine treatment

in Psychopharmacology

René Zeiss
Melissa Schweizer
Bernhard Connemann
Kathrin Malejko

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1450092

2,391 views
2 citations

Case Report

Published on 16 Jul 2024

Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report

in Psychopharmacology

André Do
Vanessa Michaud
Jean-François Stephan
Miltiadis Moreau
Élise Benoît
Félix-Antoine Bérubé
Antoine Bibaud-De Serres
Alain Taillefer
Philippe Vincent

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1394962

6,286 views
1 citation

Original Research

Published on 15 Jul 2024

Increased antipsychotic drug concentration in hospitalized patients with mental disorders following COVID-19 infection: a call for attention

in Psychopharmacology

Rui Yang
Jin-Ling Wan
Chen-Qi Pi
Tian-Hui Wang
Xue-Quan Zhu
Shuang-Jiang Zhou

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1421370

2,063 views
1 citation

Editorial

Published on 04 Jul 2024

Editorial: Exploring prevention strategies and treatment in addictive disorders

in Psychopharmacology

Sandra Montagud-Romero
Victoria Gómez-Murcia
Francisco José Fernández-Gómez
Cristina Núñez

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1432822

1,489 views

Original Research

Published on 04 Jul 2024

Association between benzodiazepine anxiolytic polypharmacy and concomitant psychotropic medications in Japan: a retrospective cross-sectional study

in Psychopharmacology

Masahiro Takeshima
Kazuhisa Yoshizawa
Masaya Ogasawara
Mizuki Kudo
Yu Itoh
Naoko Ayabe
Nana Shibata
Kazuo Mishima

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1405049

2,023 views
1 citation

Review

Published on 24 Jun 2024

Ketamine in the effective management of chronic pain, depression, and posttraumatic stress disorder for Veterans: A meta-analysis and systematic review

in Psychopharmacology

Jenny J.W. Liu
Natalie Ein
Julia Gervasio
Clara Baker
Rachel Plouffe
Sonya Wanklyn
Amer M. Burhan
Brenda Lau
Emmanuel Abreu
Thomas Wasiuta

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1338581

4,643 views
1 citation

Original Research

Published on 19 Jun 2024

Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia

in Psychopharmacology

Júlio César Menezes Vieira
Edna Afonso Reis
Augusto Afonso Guerra
Helian Nunes de Oliveira
Cristina Mariano Ruas

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1421501

2,543 views

Original Research

Published on 18 Jun 2024

Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System

in Psychopharmacology

Tigran Makunts
Ruben Abagyan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1414622

2,586 views
1 citation

Original Research

Published on 11 Jun 2024

Nicotine and fluoxetine alter adolescent dopamine-mediated behaviors via 5-HT1A receptor activation

in Psychopharmacology

Menglu Yuan
Frances M. Leslie

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1380123

2,921 views
3 citations

Editorial

Published on 10 Jun 2024

Editorial: Down the rabbit hole – the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions

in Psychopharmacology

Leehe Peled-Avron
Jacob S. Aday
Amilia Lydia Kalafateli
Holly K. Hamilton
Joshua D. Woolley

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1431389

2,417 views

Review

Published on 10 Jun 2024

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids

in Psychopharmacology

David J. Heal
Jane Gosden
Sharon L. Smith

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1322434

4,203 views
6 citations

Methods

Published on 04 Jun 2024

Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”

in Psychopharmacology

Julia Bornemann
James B. Close
Kirran Ahmad
Tommaso Barba
Kate Godfrey
Lauren Macdonald
David Erritzoe
David Nutt
Robin Carhart-Harris

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1320780

9,681 views
2 citations

Editorial

Published on 27 May 2024

Editorial: Perspectives on new fast-acting antidepressants

in Psychopharmacology

Rodrigo Simonini Delfino
Balwinder Singh
Acioly L. T. Lacerda

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1430990

1,576 views

Original Research

Published on 21 May 2024

A 12-month longitudinal naturalistic follow-up of cariprazine in schizophrenia

in Psychopharmacology

Claudia Carmassi
Valerio Dell’Oste
Sara Fantasia
Andrea Bordacchini
Carlo Antonio Bertelloni
Pietro Scarpellini
Virginia Pedrinelli

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1382013

2,190 views